Nimodipine semi-solid capsules containing solid dispersion for improving dissolution.

[1]  Chandra Vemavarapu,et al.  Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: selection of polymer-surfactant combinations using solubility parameters and testing the processability. , 2007, International journal of pharmaceutics.

[2]  R. Chokshi,et al.  Characterization of physico-mechanical properties of indomethacin and polymers to assess their suitability for hot-melt extrusion processs as a means to manufacture solid dispersion/solution. , 2005, Journal of pharmaceutical sciences.

[3]  V. L. Bagirova,et al.  Modern Auxiliary Substances in Tablet Production: Use of High-Molecular-Weight Compounds for the Development of New Medicinal Forms and Optimization of Technological Processes , 2005, Pharmaceutical Chemistry Journal.

[4]  Abdul W. Basit,et al.  Concentration-Dependent Effects of Polyethylene Glycol 400 on Gastrointestinal Transit and Drug Absorption , 2003, Pharmaceutical Research.

[5]  J. Crison,et al.  A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability , 1995, Pharmaceutical Research.

[6]  Zhao Fengsheng.  The Effects of PEG on the Solubility of Nimodipine , 2004 .

[7]  S. Ozkan,et al.  Enhanced bioavailability of piroxicam using Gelucire 44/14 and labrasol: in vitro and in vivo evaluation. , 2003, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[8]  J. Breitenbach.  Melt extrusion: from process to drug delivery technology. , 2002, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[9]  S. Benita,et al.  Self-dispersing lipid formulations for improving oral absorption of lipophilic drugs. , 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[10]  J Dressman,et al.  Improving drug solubility for oral delivery using solid dispersions. , 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[11]  A. Wallin,et al.  The Scandinavian Multi-Infarct Dementia Trial: a double-blind, placebo-controlled trial on nimodipine in multi-infarct dementia , 2000, Journal of the Neurological Sciences.

[12]  M. Hennerici,et al.  Meta-Analysis of Oral Nimodipine Trials in Acute Ischemic Stroke , 1994 .

[13]  M. S. Langley,et al.  Nimodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cerebrovascular disease. , 1989, Drugs.

[14]  P. Jakobsen,et al.  Determination of nimodipine by gas chromatography using electron-capture detection; external factors influencing nimodipine concentrations during intravenous administration. , 1986, Journal of chromatography.

[15]  S. E. Walker,et al.  The filling of molten and thixotropic formulations into hard gelatin capsules , 1980, The Journal of pharmacy and pharmacology.